Graphene as cancer theranostic tool: progress and future challenges

Marco Orecchioni1, Roberto Cabizza1, Alberto Bianco2

  • 11. Department of Chemistry and Pharmacy, University of Sassari , via muroni 23 07100 Sassari, Italy.

Theranostics
|April 22, 2015
PubMed

Insights

Graphene and its derivatives show promise for advanced cancer theranostics, combining diagnosis and therapy. Research indicates significant growth in graphene-based drug delivery, photothermal therapy, and imaging for improved cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Cancer remains a leading global cause of death, necessitating improved diagnostic and therapeutic strategies.
  • Traditional cancer treatments face limitations due to lack of specificity and systemic toxicity.
  • Nanomaterials offer potential for targeted cancer therapy with reduced side effects and integrated diagnosis.

Purpose of the Study:

  • To comprehensively review literature on graphene and its derivatives (graphene oxide, reduced graphene oxide) for cancer therapy and diagnosis.
  • To analyze the current state-of-the-art in graphene-based cancer theranostics.
  • To identify future challenges and innovative applications of graphene in oncology.

Main Methods:

  • Systematic literature review of studies utilizing graphene-based materials for cancer treatment and diagnosis.
  • Analysis of application trends, including drug/gene delivery, photothermal therapy, imaging, and theranostics.
  • Categorization of research based on combined diagnostic and therapeutic modalities.

Main Results:

  • Significant and increasing research interest in graphene for cancer applications.
  • Dominant applications include drug/gene delivery (73%), photothermal therapy (32%), and imaging (31%).
  • Theranostic applications, combining imaging and therapy, are a growing area (27%).

Conclusions:

  • Graphene-based cancer theranostics are in an early but rapidly advancing stage.
  • The integration of diagnosis and therapy using nanomaterials like graphene holds revolutionary potential for medicine.
  • Further research is needed to overcome challenges and realize the full potential of graphene in personalized cancer care.